October 6, 2008
 
Pharmascience Inc.
 
 
|
Defence to a multi-billion dollar class-action filed against eight generic drug manufacturers for the reimbursement of alleged rebates paid to pharmacists and challenge to new provisions of the Code of Civil Procedure relating to the authorization of class-actions on the basis of the Québec Charter of Human Rights and Freedoms (before the Superior Court of Québec).

|
2004